Lutein interacts with ascorbic acid more frequently than with alpha-tocopherol to alter biomarkers of oxidative stress in female zucker obese rats.
The influence of dietary lutein, with and without moderate amounts of vitamin C (VC) or vitamin E (VE), on biomarkers of oxidative stress was examined in rats. Nine groups of immature Zucker obese (fa/fa) and lean female rats (8/group) consumed ad libitum for 8 wk the AIN-93G diet (Control) to which was added either dl-alpha-tocopherol acetate (VE) at 0.60 mg/kg or ascorbic acid (VC) at 0.75 mg/kg diet. Each of these diets contained lutein oil (FloraGlo) at 0.5 (Lut0.5) or 1.0 (Lut1.0) mg/kg diet. Weight gain, food efficiency and relative liver weight were higher in obese than in lean rats. Although liver malondialdehyde (MDA) concentrations were significantly higher in obese than in lean rats, levels were significantly lower in obese rats fed VE, VE-Lut and VC-Lut0.5 compared with other obese groups. The accumulation of alpha-tocopherol in liver was 6- and 3-times greater in the VE and VE-Lut1.0 groups, respectively, compared with the obese and lean control groups. Lutein reduced the activity of superoxide dismutase (SOD) in obese rats, independent of VC or VE, and raised the activity of glutathione peroxidase to higher levels in lean rats when combined with VC. Plasma insulin levels were dramatically higher in obese compared with lean rats, but significantly lower in obese rats fed VC-Lut0.5, VE-Lut1.0 and Lut1.0 compared with the Control group. These results suggest that lutein independently reduces the activity of SOD and alters more biomarkers of oxidative stress when combined with vitamin C than with vitamin E, and that vitamin E reduces liver lipid peroxidation in obese rats when the accumulation of liver alpha-tocopherol is very high.
Blakely
Shirley
S
Food and Drug Administration, College Park, MD 20740, USA. sblakely@cfsan.fda.gov
Herbert
Arnetra
A
Collins
Michelle
M
Jenkins
Mamie
M
Mitchell
Geraldine
G
Grundel
Erich
E
O'Neill
Karen R
KR
Khachik
Frederick
F
D000818:Animals; D001205:Ascorbic Acid / Q000008:administration & dosage / Q000378:metabolism*; D015415:Biomarkers / Q000032:analysis; D003345:Corticosterone / Q000097:blood; D004305:Dose-Response Relationship, Drug; D004338:Drug Combinations; D005260:Female; D005978:Glutathione / Q000378:metabolism; D007328:Insulin / Q000097:blood; D015227:Lipid Peroxidation; D008099:Liver / Q000378:metabolism; D014975:Lutein / Q000008:administration & dosage / Q000097:blood / Q000378:metabolism*; D008315:Malondialdehyde / Q000378:metabolism; D009765:Obesity / Q000378:metabolism*; D009994:Osmolar Concentration; D018384:Oxidative Stress; D051381:Rats; D011924:Rats, Zucker; D013482:Superoxide Dismutase / Q000378:metabolism; D013851:Thinness / Q000097:blood / Q000378:metabolism; D024502:alpha-Tocopherol / Q000008:administration & dosage / Q000378:metabolism*
D015415:Biomarkers; D004338:Drug Combinations; D007328:Insulin; D008315:Malondialdehyde; D013482:Superoxide Dismutase; D005978:Glutathione; D024502:alpha-Tocopherol; D001205:Ascorbic Acid; D003345:Corticosterone; D014975:Lutein